Piper Sandler Forecasts Strong Price Appreciation for IDEXX Laboratories (NASDAQ:IDXX) Stock
IDEXX Laboratories (NASDAQ:IDXX – Free Report) had its price objective upped by Piper Sandler from $435.00 to $510.00 in a research report report published on Monday morning,Benzinga reports. Piper Sandler currently has a neutral rating on the stock. A number of other analysts also recently issued reports on IDXX. StockNews.com downgraded IDEXX Laboratories from a […]
